Minimum Inhibitory Concentration Report Form

CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis and Nontuberculous Mycobacteria Drug Susceptibility Testing

Att. 9-MIC Results Form

Minimum Inhibitory Concentration Reports

OMB: 0920-0600

Document [docx]
Download: docx | pdf







CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing

Attachment 9


MPEP Mycobacterium. tuberculosis Minimum Inhibitory Concentration (MIC) Results Form







































Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-0600)

MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration (MIC) Results Form

Enter your minimum inhibitory concentration and drug susceptibility test result interpretation for each isolate tested by Sensititre by using the data worksheet below. Please complete one worksheet per isolate in addition to the online data entry. For laboratories who customize Sensititre plates, please use ‘Other’ for any additional antituberculosis drugs tested.

Completed worksheets should be emailed to TBMPEP@cdc.gov prior to the submission deadline.

MPEP Number                     

Isolate      

Drug

MIC

Resistant

Susceptible

Borderline

Contaminated

No Growth

Not Done

Rifampin


Isoniazid


Ethambutol










Streptomycin


Ofloxacin


Ciprofloxacin


Moxifloxacin


Levofloxacin


Amikacin


Kanamycin


Capreomycin


Ethionamide


Rifabutin


Cycloserine


Para-Amino Salicyclic Acid


Other:


Other:


Other:







File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorYakrus, Mitchell (CDC/OID/NCHHSTP)
File Modified0000-00-00
File Created2021-01-20

© 2024 OMB.report | Privacy Policy